Comparable stake leader
Indaba Capital Management, L.P.
SEC ownership of Accelerate Diagnostics, Inc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000727207.
Disclosed value leader
Jack W. Schuler
Comparable rows
3/21
Latest evidence
04 Apr 2025
- Parsed ownership sources
- 13D/G and 3/4/5
- Largest SEC-reported holder
- Indaba Capital Management, L.P.
- Latest 13D/G holder
- Indaba Capital Management, L.P.
- Latest parsed ownership date
- 04 Apr 2025
- Issuer CIK
- 0000727207
- Issuer location
- Tucson, AZ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Accelerate Diagnostics, Inc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Indaba Capital Management...
Disclosed value leader
Jack W. Schuler
Comparable rows
3/21
Latest evidence
04 Apr 2025
13D/G
3/4/5
Lead comparable stake: 9.9%
18 rows are not safely comparable across share classes.
13D/G row: Indaba Capital Management, L.P.
Showing 1-8 of 21 holder rows.
Quick read
Indaba Capital Management, L.P. leads the comparable SEC ownership view at 9.9%.
3 of 21 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Indaba Capital Management, L.P.'s linked filing trail.
Comparable ownership
Top 3
Indaba Capital Management, L.P.
9.9%
ARMISTICE CAPITAL, LLC
7.4%
GRIFFIN ASSET MANAGEMENT, INC.
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 21 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Indaba Capital Management, L.P. |
13D/G
|
9.9%
|
$2,146,374
2,751,762 shares
|
$0 | 04 Feb 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
7.4%
|
$995,990
1,879,227 shares
|
-$105,350 | 31 Mar 2025 |
| GRIFFIN ASSET MANAGEMENT, INC. |
13D/G
Griffin Asset Management, LLC
|
4%
|
$531,898
1,003,581 shares
|
$0 | 31 Dec 2024 |
| Jack W. Schuler |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$13,104,365
11,071,820 shares
mixed-class rows
|
— | 03 Dec 2024 |
| Matthew W. Strobeck |
3/4/5
Director
|
—
mixed-class rows
|
$2,467,531
662,080 shares
mixed-class rows
|
— | 23 Jan 2024 |
| John Patience |
3/4/5
Director
|
—
mixed-class rows
|
$1,419,801
954,544 shares
mixed-class rows
|
— | 03 Dec 2024 |
| Mark S. Black |
3/4/5
Director
|
—
mixed-class rows
|
$1,098,403
303,509 shares
mixed-class rows
|
— | 20 May 2024 |
| Marran H. Ogilvie |
3/4/5
Director
|
—
mixed-class rows
|
$1,098,403
303,509 shares
mixed-class rows
|
— | 20 May 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 06 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 20 reporting-owner rows connected to Accelerate Diagnostics, Inc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
20
Largest Forms 3/4/5 holder
Jack W. Schuler
Net 12M change
$0
Latest report
10 Apr 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jack W. Schuler | Director, 10%+ Owner | $13,104,365 | Mixed | 03 Dec 2024 | ||
| Matthew W. Strobeck | Director | $2,467,531 | Mixed | 23 Jan 2024 | ||
| John Patience | Director | $1,419,801 | Mixed | 03 Dec 2024 | ||
| Marran H. Ogilvie | Director | $1,098,403 | Mixed | 20 May 2024 | ||
| Mark S. Black | Director | $1,098,403 | Mixed | 20 May 2024 | ||
| Jennifer Regan | Director | $1,067,524 | Mixed | 29 May 2024 | ||
| Wayne Burris | Director | $1,043,428 | Mixed | 31 May 2024 | ||
| Steven Reichling | Chief Financial Officer | $625,004 | Mixed | 13 Mar 2023 | ||
| Thomas D. Brown | Director | $509,942 | Mixed | 19 May 2023 | ||
| Mark C. Miller | Director | $414,170 | Mixed | 07 Mar 2023 | ||
| Charles M. Watts | Director | $305,627 | Mixed | 19 May 2023 | ||
| Brink Frank Jm Ten | Director | $266,412 | Mixed | 03 Mar 2023 | ||
| Ron Price | Head of Commercial Operations | $178,278 | Mixed | 21 Apr 2022 | ||
| Jack Phillips | Chief Executive Officer, Director | $124,393 | Filing P/S | 04 Apr 2025 | ||
| David Patience | Chief Financial Officer | $67,683 | Mixed | 01 Apr 2025 | ||
| Larry Michael Mertz | Chief Technology Officer | $55,122 | Filing P/S | 04 Apr 2025 | ||
| Hany Massarany | Director | $51,777 | Mixed | 28 Jun 2024 | ||
| Louise Francesconi | Director | $46,204 | Mixed | 28 Jun 2024 | ||
| Gilbert E. Nathan | Director | Mixed | 10 Apr 2025 | |||
| Paul Vincent Shalhoub | Director | Mixed | 10 Apr 2025 |
Recent insider transactions for Accelerate Diagnostics, Inc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.